Dr. Granton is a staff physician at UHN, serving on the multi-disciplinary intensive care intensive care unit at the Toronto General Hosptial that specializes in the management of organ transplant recipients, advanced respiratory failure and sepsis, and supports advanced medical and surgical programmes.He is also Director of the Pulmonary Hypertension programme at the Toronto General Hospital and conducts research through TGHRI. Dr. Granton's clinical research focuses on lung injury, shock, thrombosis, and pulmonary vascular disease.
Specific research interests include:
- Pulmonary hypertension
- Congenital heart disease
- Exercise testing
- Heart-lung interactions
Am J Respir Crit Care Med. 2020 Feb 15;201(4):396-398
Heliyon. 2019 Jul;5(7):e02034
Pulmonary hypertension in patients with a subaortic right ventricle: prevalence, impact and management.
Heart. 2019 May 03;:
Osteopontin lung gene expression is a marker of disease severity in pulmonary arterial hypertension.
Respirology. 2019 Apr 08;:
Myeloid angiogenic cells exhibit impaired migration, reduced expression of endothelial markers and increased apoptosis in idiopathic pulmonary arterial hypertension.
Can J Physiol Pharmacol. 2018 Dec 17;:
Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study.
Res Pract Thromb Haemost. 2018 Oct;2(4):670-677
Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study.
Lancet. 2018 Jun 30;391(10140):2631-2640
Cardiovasc Res. 2018 Jun 06;:
Rheum Dis Clin North Am. 2018 May;44(2):361-370
Rheum Dis Clin North Am. 2018 May;44(2):203-213
Clinician Investigator, Toronto General Hospital Research Institute (TGHRI)
Associate Professor, Department of Medicine, University of Toronto